<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01529099</url>
  </required_header>
  <id_info>
    <org_study_id>CT10/01</org_study_id>
    <nct_id>NCT01529099</nct_id>
  </id_info>
  <brief_title>Postmarketing Study to Determine Performance of the SIGMA HP速 PARTIAL KNEE SYSTEM</brief_title>
  <official_title>A Prospective, Non-comparative, Single Centre Study to Determine the Performance &amp; Survivorship of the SIGMA HP速 PARTIAL KNEE SYSTEM.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>DePuy International</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>DePuy International</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a postmarketing study to assess the overall performance and survivorship of the SIGMA
      HP速 PARTIAL KNEE SYSTEM.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to collect more information about the Sigma HP速 Partial Knee
      System made by DePuy International. The aim of this study is to measure how this particular
      type of knee replacement performs over a two year period.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">January 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survivorship (revision)</measure>
    <time_frame>2 years</time_frame>
    <description>Kaplan Meier Survival analysis at 2 years (based on revision of the femoral or tibial components)</description>
  </primary_outcome>
  <other_outcome>
    <measure>Types and Frequency of Adverse Events</measure>
    <time_frame>Throughout the study</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Clinical outcome using the AKS score</measure>
    <time_frame>6 weeks, 6 months, 1 year and 2 years post-op</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Patient-reported outcome using the KOOS assessment</measure>
    <time_frame>6 weeks, 6 months, 1 year and 2 years post-op</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Patient-reported outcome using the HAAS assessment</measure>
    <time_frame>6 weeks, 6 months, 1 year and 2 years post-op</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Patient-reported outcome using the Kujala score</measure>
    <time_frame>6 weeks, 6 months, 1 year and 2 years post-op</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Patient-reported outcome using the Oxford Knee Score</measure>
    <time_frame>6 weeks, 6 months, 1 year and 2 years post-op</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Patient-reported outcome using the EQ-5D assessment</measure>
    <time_frame>6 weeks, 6 months, 1 year and 2 years post-op</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Radiographic assessment</measure>
    <time_frame>6 weeks, 6 months, 1 year and 2 years post-op</time_frame>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Osteoarthritis</condition>
  <condition>Post-traumatic Arthritis</condition>
  <condition>Gout</condition>
  <condition>Pseudo-gout</condition>
  <arm_group>
    <arm_group_label>Sigma HP Partial Knee</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Partial knee replacement</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SIGMA HP PARTIAL KNEE</intervention_name>
    <description>SIGMA HP PARTIAL KNEE</description>
    <arm_group_label>Sigma HP Partial Knee</arm_group_label>
    <other_name>Sigma HP Partial Knee Femoral component</other_name>
    <other_name>Sigma HP Partial Knee Tibial component</other_name>
    <other_name>Sigma HP Partial Knee Tibial insert component</other_name>
    <other_name>Sigma Patellae</other_name>
    <other_name>Sigma HP Partial Knee Trochlear component</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female subjects, aged at least 21 years.

          -  Subjects who are able to give voluntary, written informed consent to participate in
             this clinical investigation and from whom consent has been obtained.

          -  Subjects, who, in the opinion of the Clinical Investigator, are able to understand
             this clinical investigation, co-operate with the investigational procedures and are
             willing to return to the hospital for all the required post-operative follow-ups.

          -  Subject has non-inflammatory degenerative joint disease (NIDJD), including:
             osteoarthritis, posttraumatic arthritis, avascular necrosis and chondrocalcinosis.

          -  Subject has a functional stable knee.

          -  Subject, in the opinion of the Investigator, is suitable for either a single or
             bicompartmental knee replacement.

          -  Subject meets the following selected radiographic parameters:

               -  X-ray evaluation confirms the presence of NIDJD

               -  Disease location: 1 to 2 compartments, maximum. Disease can be present in the
                  patellofemoral compartment, the medial tibiofemoral compartment, lateral
                  tibiofemoral compartments alone or in any two compartments.

               -  Disease severity: Kellgren and Lawrence44 Grade II or greater for all
                  compartments replaced.

        Exclusion Criteria:

          -  Subjects who, in the opinion of the Clinical Investigator, have an existing condition
             that would compromise their participation and follow-up in this clinical
             investigation.

          -  Women who are pregnant.

          -  Subjects who are known drug or alcohol abusers or with psychological disorders that
             could affect follow-up care or treatment outcomes.

          -  Subjects who have participated in a clinical investigation with an investigational
             product in the last 3 months.

          -  Subjects who are currently involved in any injury litigation claims.

          -  Multiple joint involvement that will compromise rehabilitation (for example: advanced
             hip, ankle or spine disease).

          -  Known to be a prisoner, mentally incompetent, an alcohol / drug abuser, involved in
             medical-legal case or worker's compensation

          -  Previous knee arthroplasty (any type) in any one of the three compartments of the
             knee.

          -  Requires more than a lateral soft tissue release or an anterior cruciate ligament
             reconstruction.

          -  Uncorrectable anatomical tibio-femoral angle.

          -  Bone deficiency requiring structural bone grafts to support the implants.

          -  Previous patellectomy.

          -  For Subjects indicated for a patellofemoral arthroplasty, Subject has uncorrected
             patella baja (Caton-Deschamps ratio less than or equal to 0.6).

          -  Tri-compartmental disease process (patella-femoral, medial tibio-femoral and lateral
             tibio-femoral).

          -  Active bacterial infection that may spread to other areas of the body (e.g.,
             osteomyelitis, pyogenic infection of knee joint, urinary tract infection, etc.).

          -  Significant neurological or musculoskeletal deformity or a disease that may affect
             gait or weight bearing, (e.g., muscular dystrophy, multiple sclerosis, amputation).

          -  Known allergy to implant materials.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Orthopedic Institute IRCCS Galeazzi</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CDC, Citta di Palma</name>
      <address>
        <city>Parma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Schulthess Klinik</name>
      <address>
        <city>Zurich</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
    <country>Switzerland</country>
  </location_countries>
  <removed_countries>
    <country>France</country>
    <country>Germany</country>
    <country>United Kingdom</country>
  </removed_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2011</study_first_submitted>
  <study_first_submitted_qc>February 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2012</study_first_posted>
  <last_update_submitted>May 27, 2016</last_update_submitted>
  <last_update_submitted_qc>May 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Osteoarthritis</keyword>
  <keyword>Knee</keyword>
  <keyword>Knee replacement</keyword>
  <keyword>Knee implant</keyword>
  <keyword>Knee arthroplasty</keyword>
  <keyword>Unicompartmental</keyword>
  <keyword>Primary</keyword>
  <keyword>Partial</keyword>
  <keyword>Patellofemoral</keyword>
  <keyword>Medial</keyword>
  <keyword>Lateral</keyword>
  <keyword>Bicompartmental</keyword>
  <keyword>Cemented</keyword>
  <keyword>Post-traumatic arthritis of the tibio-femoral and/or patellofemoral articular surfaces</keyword>
  <keyword>History of Gout or pseudo-gout.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Gout</mesh_term>
    <mesh_term>Chondrocalcinosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

